Literature DB >> 10093866

Sense and nonsense: an essay on schizophrenia research ethics.

W T Carpenter1, R R Conley.   

Abstract

In this essay, the authors select topics from the current debate on the ethics of schizophrenia research. Accepting competent and voluntary informed consent as essential for most projects, the authors discuss the relation of diagnosis to decisional capacity, the respective roles of psychosis and cognitive impairments in decisional capacity, and whether impairments in capacity can be remediated. The roles of investigator, external agent, patient subject, and family or surrogate in the informed consent process are reviewed. A lack of understanding of the treatment of persons with schizophrenia has distorted and inflamed public discussion of issues such as 'withholding treatment'. A standard, based in common sense, is proposed: for viewing protocols; for allowing autonomy and altruism despite diagnostic class; and, for a meaningful discussion of what is meant by and what should be done about 'risk without direct benefit' protocols.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Substances:

Year:  1999        PMID: 10093866     DOI: 10.1016/s0920-9964(98)00128-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Ethical issues in schizophrenia research.

Authors:  R B Zipursky
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Decisional capacity and consent for schizophrenia research.

Authors:  Allison R Kaup; Laura B Dunn; Elyn R Saks; Dilip V Jeste; Barton W Palmer
Journal:  IRB       Date:  2011 Jul-Aug

Review 3.  Placebo in the investigation of psychotropic drugs, especially antidepressants.

Authors:  Stanisław Puzyński
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

4.  Picturing neuroscience research through a human rights lens: imaging first-episode schizophrenic treatment-naive individuals.

Authors:  Marleen Eijkholt; James A Anderson; Judy Illes
Journal:  Int J Law Psychiatry       Date:  2012-02-02

5.  Traditional ethics and new sensitivities.

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2005-11-17       Impact factor: 9.306

Review 6.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

7.  Do human subject safeguards matter to potential participants in psychiatric genetic research?

Authors:  Laura Weiss Roberts; Jane Paik Kim; Tenzin Tsungmey; Laura B Dunn
Journal:  J Psychiatr Res       Date:  2019-06-08       Impact factor: 4.791

8.  Perspectives on medical research involving men in schizophrenia and HIV-related protocols.

Authors:  Laura Weiss Roberts; Teddy D Warner; Katherine A Green Hammond; Cynthia M A Geppert
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

9.  Successful recruitment to trials: findings from the SCIMITAR+ Trial.

Authors:  Emily Peckham; Catherine Arundel; Della Bailey; Tracy Callen; Christina Cusack; Suzanne Crosland; Penny Foster; Hannah Herlihy; James Hope; Suzy Ker; Tayla McCloud; Crystal-Bella Romain-Hooper; Alison Stribling; Peter Phiri; Ellen Tait; Simon Gilbody
Journal:  Trials       Date:  2018-01-19       Impact factor: 2.279

10.  Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness.

Authors:  Louise Howard; Isabel de Salis; Zelda Tomlin; Graham Thornicroft; Jenny Donovan
Journal:  Contemp Clin Trials       Date:  2008-07-31       Impact factor: 2.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.